← The Wire
FTRENasdaq
Fortrea Holdings Inc.
Services-Medical Laboratories · CIK 1965040
Fortrea Holdings Inc. provides biopharmaceutical and medical device development solutions, including clinical trial management and consulting
red 8-K · 90d
$1.56B
Market cap
$17.52
Last close
-0.7%
1D
+12.6%
5D
1.2M
Volume
Price · last 39 sessions+43.0%
May 4L $12.25 · H $17.71Jun 29
67
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Reg FD DisclosureJun 26, 20268-KShareholder VoteJun 12, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureNov 20, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KExecutive Change · Reg FD DisclosureSep 22, 20258-KExecutive ChangeAug 27, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive Change · Shareholder VoteJun 12, 20258-KMaterial Agreement · Security-Holder RightsJun 12, 20258-KExecutive Change · Reg FD DisclosureJun 11, 20258-K/AExecutive ChangeMay 15, 2025DEFA14ADEFA14AMay 15, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 20258-KExecutive Change · Reg FD DisclosureMay 12, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KExecutive ChangeMar 10, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KExecutive Change · Material AgreementFeb 21, 2025SC 13GSC 13GNov 12, 202410-Q10-QNov 8, 20248-KResults of OperationsNov 8, 20248-K/AExecutive ChangeAug 26, 202410-Q10-QAug 12, 20248-KResults of OperationsAug 12, 20248-KExecutive Change · Reg FD DisclosureJul 11, 20248-KReg FD DisclosureJun 20, 20248-K/AReg FD DisclosureJun 7, 20248-KReg FD DisclosureJun 4, 20248-KReg FD DisclosureMay 24, 202410-Q10-QMay 24, 20248-KExecutive Change · Shareholder VoteMay 16, 20248-KResults of OperationsMay 13, 20248-KMaterial Agreement · New Debt / ObligationMay 9, 20248-KExecutive ChangeApr 1, 2024DEFA14ADEFA14AMar 28, 2024DEF 14ADEF 14AMar 28, 202410-K10-KMar 13, 20248-KResults of Operations · Reg FD DisclosureMar 11, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GJan 25, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KReg FD DisclosureNov 29, 20238-KCompany UpdateNov 21, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 2023SC 13DTHE SCHEDULE 13DOct 17, 20238-K/AResults of OperationsAug 24, 20238-KExecutive ChangeAug 21, 202310-Q10-QAug 14, 20238-KResults of Operations · Reg FD DisclosureAug 14, 2023SC 13GSCHEDULE 13GAug 10, 2023SC 13GSC 13GAug 8, 20238-KChange of Control · Executive ChangeJul 3, 20238-KMaterial Agreement · New Debt / ObligationJun 30, 20238-KExecutive ChangeJun 21, 20238-KReg FD DisclosureJun 12, 2023
Insider Activity
In the 90 days to Mar 16, 2026: 3 sold $167K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Morais Mark A.Chief Operating Officer | Sell | 1,804 | $9.22 | $17K |
| Mar 16, 2026 | Mcconnell Jill G.Chief Financial Officer | Sell | 1,804 | $9.22 | $17K |
| Mar 10, 2026 | Mcconnell Jill G.Chief Financial Officer | Sell | 2,531 | $9.21 | $23K |
| Mar 10, 2026 | Mcconnell Jill G.Chief Financial Officer | Sell | 2,530 | $8.93 | $23K |
| Mar 10, 2026 | Morais Mark A.Chief Operating Officer | Sell | 2,300 | $9.21 | $21K |
| Mar 10, 2026 | Morais Mark A.Chief Operating Officer | Sell | 2,299 | $8.93 | $21K |
| Mar 10, 2026 | Parks RobertChief Accounting Officer | Sell | 964 | $9.21 | $9K |
| Mar 10, 2026 | Parks RobertChief Accounting Officer | Sell | 963 | $8.93 | $9K |
| Feb 10, 2026 | Morais Mark A.Chief Operating Officer | Sell | 590 | $14.11 | $8K |
| Feb 10, 2026 | Morais Mark A.Chief Operating Officer | Sell | 589 | $13.65 | $8K |
| Feb 10, 2026 | Mcconnell Jill G.Chief Financial Officer | Sell | 441 | $14.11 | $6K |
| Feb 10, 2026 | Mcconnell Jill G.Chief Financial Officer | Sell | 440 | $13.65 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance